EXPERIMENTAL STUDIES
8-Chloro-cAMP inhibits smooth muscle cell proliferation in vitro and neointima formation induced by balloon injury in vivo
Ciro Indolfi, MD, FACCa,
Emilio Di Lorenzo, MDa,
Antonio Rapacciuolo, MDa,
Angela Maria Stingone, MDa,
Eugenio Stabile, MDa,
Antonio Leccia, MDa,
Daniele Torella, MDa,
Rosa Caputo, MD*,
Fortunato Ciardiello, MD*,
Gianpaolo Tortora, MD* and
Massimo Chiariello, MD, FACCa
a Laboratory of Experimental and Clinical Interventional Cardiology, University Federico II, Naples, Italy
* Department of Molecular and Clinical Endocrinology and Oncology, University Federico II, Naples, Italy
Manuscript received January 28, 1999;
revised manuscript received January 17, 2000,
accepted March 2, 2000.
Reprint requests and correspondence: Dr. Ciro Indolfi, Division of Cardiology, University Federico II, Via Pansini, 5, 80131 Napoli, Italy Indolfi{at}unina.it
OBJECTIVES
The aims of the present study were to assess 1) the effect of 8-Cl-cAMP (cyclic-3'-5'-adenosine monophosphate) on vascular smooth muscle cell (VSMC) proliferation in vitro and 2) the efficacy of systemic administration of 8-Cl-cAMP on neointimal formation after balloon injury in vivo.
BACKGROUND
Neointimal formation after vascular injury is responsible for restenosis after arterial stenting. Recently, 8-Cl-cAMP, a cAMP analogue that induces growth arrest, has been safely administered in phase I studies in humans.
METHODS
The effect of 8-Cl-cAMP on cell proliferation was first assessed on SMCs in vitro. To study the effects of cAMP in vivo, balloon injury was performed in 67 rats using a 2F Fogarty balloon catheter.
RESULTS
The 8-Cl-cAMP markedly inhibited VSMC proliferation in vitro, reduced protein kinase A (PKA) RI subunit expression, and induced PKA RIIß subunit expression. In addition, 8-Cl-cAMP reduced, in a dose-dependent manner, neointimal area and neointima/media ratio after balloon injury. The proliferative activity, assessed by proliferating nuclear cell antigen immunostaining, revealed a reduction of proliferative activity of VSMCs in vivo in the 8-Cl-cAMP group. Moreover, the systemic administration of 8-Cl-cAMP did not affect renal function, blood pressure and heart rate.
CONCLUSIONS
We conclude that 8-Cl-cAMP potently inhibits VSMC proliferation in vitro and reduces neointima formation by balloon injury in vivo after systemic administration. These data may have a clinical relevance in designing future strategies to prevent restenosis after arterial stenting and perhaps after percutaneous transluminal coronary angioplasty.
|
Abbreviations and Acronyms
| | ANOVA | = analysis of variance | | cAMP | = cyclic-3'-5'-adenosine monophosphate | | DMEM | = Dulbeccos modified Eagles medium | | EEL | = external elastic membrane | | FCS | = fetal calf serum | | IEL | = internal elastic membrane | | PCNA | = proliferating cell nuclear antigen | | PKA | = protein kinase A | | PTCA | = percutaneous transluminal coronary angioplasty | | VSMCs | = vascular smooth muscle cells |
|
This article has been cited by other articles:

|
 |

|
 |
 
U. Yokoyama, S. Minamisawa, H. Quan, T. Akaike, M. Jin, K. Otsu, C. Ulucan, X. Wang, E. Baljinnyam, M. Takaoka, et al.
Epac1 is upregulated during neointima formation and promotes vascular smooth muscle cell migration
Am J Physiol Heart Circ Physiol,
October 1, 2008;
295(4):
H1547 - H1555.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. G. Tilley and D. H. Maurice
Vascular Smooth Muscle Cell Phenotype-Dependent Phosphodiesterase 4D Short Form Expression: Role of Differential Histone Acetylation on cAMP-Regulated Function
Mol. Pharmacol.,
September 1, 2005;
68(3):
596 - 605.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-J. Kim, K.-G. Park, K.-M. Lee, H.-S. Kim, S.-Y. Kim, C.-S. Kim, S.-L. Lee, Y.-C. Chang, J.-Y. Park, K.-U. Lee, et al.
Cilostazol Inhibits Vascular Smooth Muscle Cell Growth by Downregulation of the Transcription Factor E2F
Hypertension,
April 1, 2005;
45(4):
552 - 556.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Sakaguchi, T. Asai, D. Belov, M. Okada, D. J. Pinsky, A. M. Schmidt, and Y. Naka
Influence of ischemic injury on vein graft remodeling: Role of cyclic adenosine monophosphate second messenger pathway in enhanced vein graft preservation
J. Thorac. Cardiovasc. Surg.,
January 1, 2005;
129(1):
129 - 137.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Torella, D. Leosco, C. Indolfi, A. Curcio, C. Coppola, G. M. Ellison, V. G. Russo, M. Torella, G. L. Volti, F. Rengo, et al.
Aging exacerbates negative remodeling and impairs endothelial regeneration after balloon injury
Am J Physiol Heart Circ Physiol,
December 1, 2004;
287(6):
H2850 - H2860.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. A. Tallant and M. A. Clark
Molecular Mechanisms of Inhibition of Vascular Growth by Angiotensin-(1-7)
Hypertension,
October 1, 2003;
42(4):
574 - 579.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Indolfi, D. Torella, C. Coppola, A. Curcio, F. Rodriguez, A. Bilancio, A. Leccia, O. Arcucci, M. Falco, D. Leosco, et al.
Physical Training Increases eNOS Vascular Expression and Activity and Reduces Restenosis After Balloon Angioplasty or Arterial Stenting in Rats
Circ. Res.,
December 13, 2002;
91(12):
1190 - 1197.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Indolfi
Genetic factors in atherosclerosis: status and perspectives
Eur. Heart J. Suppl.,
March 1, 2002;
4(suppl_B):
B14 - B16.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
S. D. Rybalkin, I. Rybalkina, J. A. Beavo, and K. E. Bornfeldt
Cyclic Nucleotide Phosphodiesterase 1C Promotes Human Arterial Smooth Muscle Cell Proliferation
Circ. Res.,
February 8, 2002;
90(2):
151 - 157.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ii, M. Hoshiga, R. Fukui, N. Negoro, T. Nakakoji, F. Nishiguchi, E. Kohbayashi, T. Ishihara, and T. Hanafusa
Beraprost sodium regulates cell cycle in vascular smooth muscle cells through cAMP signaling by preventing down-regulation of p27Kip1
Cardiovasc Res,
December 1, 2001;
52(3):
500 - 508.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. B. Jourdan, N. A. Mason, L. Long, P. G. Philips, M. R. Wilkins, and N. W. Morrell
Characterization of adenylyl cyclase isoforms in rat peripheral pulmonary arteries
Am J Physiol Lung Cell Mol Physiol,
June 1, 2001;
280(6):
L1359 - L1369.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. T. Wong, L. P. Baker, K. Trinh, M. Hetman, L. A. Suzuki, D. R. Storm, and K. E. Bornfeldt
Adenylyl Cyclase 3 Mediates Prostaglandin E2-induced Growth Inhibition in Arterial Smooth Muscle Cells
J. Biol. Chem.,
August 31, 2001;
276(36):
34206 - 34212.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. D. Rybalkin, I. Rybalkina, J. A. Beavo, and K. E. Bornfeldt
Cyclic Nucleotide Phosphodiesterase 1C Promotes Human Arterial Smooth Muscle Cell Proliferation
Circ. Res.,
February 8, 2002;
90(2):
151 - 157.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|